CRISPR/Cas systems combined with DNA nanostructures for biomedical applications

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Nanotechnology

Background:

• DNA nanostructures are versatile, biocompatible platforms for biosensing and drug delivery.
• Composite nanostructures integrate DNA with organic/inorganic materials for enhanced functionality.
• The CRISPR/Cas system is a powerful tool for gene editing and biomedical diagnostics.

Purpose of the Study:

• To review the design principles of DNA nanostructures integrated with CRISPR/Cas systems.
• To explore the biomedical applications of these combined systems, focusing on detection and drug delivery.
• To summarize the current status, challenges, and future prospects of this interdisciplinary field.

Main Methods:

• Review of existing literature on DNA nanostructures and CRISPR/Cas system integration.
• Categorization of DNA nanostructures and their combined applications.
• Analysis of design strategies and performance in detection and delivery systems.

Main Results:

• Combined DNA nanostructures and CRISPR/Cas systems enable novel detection methods.
• These integrated systems offer improved pathways for targeted drug delivery.
• The synergy expands the application scope of both DNA nanostructures and CRISPR/Cas technology.

Conclusions:

• CRISPR/Cas integrated with DNA nanostructures presents significant opportunities in biomedical fields.
• Further research is needed to overcome current challenges in detection and delivery applications.
• This synergistic approach holds promise for advancing gene editing platforms and nanomedicine.